Research and Hope Awards

PhRMA 2016 Research and Hope Awards


PhRMA, along with its distinguished co-hosts, is pleased to honor individuals and organizations with the 2016 Research & Hope Awards, which will take place on September 13 in Washington DC. This year’s program will celebrate the progress and promise of Autoimmune Research & Care. Awards will be presented in the following categories:

- Government Research

- Private / Nonprofit Research

- Biopharmaceutical Industry Research

- Excellence in Advocacy & Activism

- Community Champion

- Visibility & Progress




The Research & Hope Awards illustrate how biopharmaceutical researchers and others in the innovation ecosystem work together to not only bring new medical advances to patients, but thwart deadly diseases through increased awareness, public health efforts and increased collaboration.

Save the date

PhRMA is joined by the following 2016 Research and Hope Co-Hosts:



Mrs. Victoria Reggie Kennedy is the 2015 recipient of the Research & Hope Award for Excellence in Advocacy and Activism.

Liz and Jay Scott are recipients of the 2015 Research & Hope Award for Excellence in Visibility and Progress.

J. Silvio Gutkind, PhD is the 2015 recipient of the Research & Hope Award for Excellence in Academic Research.

Rick is the 2015 Research and Hope Community Champion Award Recipient.




Click to Review the 2014 PhRMA Research & Hope Awards Program


Bristol Myers Squibb & Company Virology Team

Hydeia Broadbent

Kathie Hiers, CEO, AIDS Alabama

Phill Wilson, President and CEO, Black AIDS Institute

Dr. Raymond Schinazi



2014 Awardee Bios

Raymond F. Schinazi, Emory University

Dennis Michael Grasela, Bristol-Myers Squibb

George Hanna, Bristol-Myers Squibb


John F. Kadow, Bristol-Myers Squibb


Mark Krystal, Bristol-Myers Squibb


Nick A. Meanwell, Bristol-Myers Squibb


Phill Wilson, Black AIDS Institute


Kathie Hiers, AIDS Alabama


Hydeia Loren Broadbent, HIV/AIDS Activist


Learn More About Treatment Progress

Treatment Advances Through Time

This interactive timeline highlights how new medicines have transformed what was once a fatal diagnosis into a chronic disease for many patients. Learn More


Look Back: HIV/AIDS Crisis

David Mixner takes a look back at how the devastation caused by the HIV/AIDS epidemic spurred the evolution of therapeutic treatment options. Learn More

HIV/AIDS Then & Now 

Since HIV/AIDS was first recognized in 1981, advances in medicines have helped lower the death rate by 83%. Learn More


44 Medicines in Development for HIV/AIDS

View the 2014 HIV/AIDS Medicines in Development report which highlights effective therapies and preventive treatments currently underway. Learn More


2014 Partners

PhRMA is joined by the following 2014 Research & Hope Co-hosts:

2014 PhRMA Research & Hope Awards Co Hosts

Click to Review the 2013 PhRMA Research & Hope Awards Program

Research & Hope Award Logo 2013

Vaccination - Prevention is better than a curePhRMA, joined by five health advocacy partners, proudly announce the recipients of the 2013 Research & Hope Awards, honoring outstanding achievements in vaccines research and immunization by individuals and research teams in the biopharmaceutical sector, academic/public research and health care provider communities.

Vaccines are one of the most profound achievements of biomedical science and public health, resulting in the eradication of smallpox, near elimination of polio, rubella and measles, and the prevention of diseases like hepatitis A and B, pneumonia and some cancers caused by viruses. Innovative vaccines and immunization practices have protected countless children and families from needless illness.

Building on this illustrious history, advances in scientific areas such as genomics are enabling researchers to develop not only new preventative vaccines, but also therapeutic vaccines for many types of cancer, HIV/AIDS, hepatitis and autoimmune disorders. Today, there are nearly 300 innovative vaccines in development by America’s biopharmaceutical research companies.


2013 PhRMA Research & Hope Awards Recipients [view the program brochure]

John J. Castellani Remarks at 2013 PhRMA Research and Hope Awards Dinner 

Thanks Anita for helping us kick-off tonight's event. Let me also thank PHRMA's Board of Directors - many of whom are with us tonight - for their enthusiastic support of the Research & Hope Awards program and for making tonight possible. Thanks as well to our great partners: the American Cancer Society Cancer Action Network, the American Nurses Association, America Osteopathic Association, Malaria No More, and the National Association of School Nurses. Each exemplifies the spirit of partnership and cooperation required to meet patient needs in the 21st Century. Read full remarks here.



Robert Hugin Remarks at 2013 PhRMA Research and Hope Awards Dinner

Thank you John and thank you Anita for hosting tonight’s celebration. Let me echo John’s welcome and thank our partners – all representing important elements of the health care ecosystem of innovation – as well as our media partners. Your support has been crucial to the success of this wonderful event. Tonight, I stand between you, a good dinner, the far more inspiring Dr. Tom Frieden and the reason we’re all here…honoring the achievements of doctors Fu, Lowy and Schiller and GlaxoSmithKline’s malaria vaccine team. Read full remarks here.


 PhRMA Research & Hope Award for Biopharmaceutical Industry Research in Vaccine Development

Award for biopharmaceutical industry research in vaccine development

GlaxoSmithKline Malaria Vaccine Team

The GlaxoSmithKline Malaria Vaccine Team, led by Dr. Sophie Biernaux, is receiving the 2013 PhRMA Research & Hope Award for Biopharmaceutical Industry Research for its ongoing development of a vaccine against malaria targeted to children in Sub-Saharan Africa. For more information on the team’s work, now in the final stages of a large, multi-center Phase III clinical trial, see the video and team bio.

Award for Academic or Public Research in Vaccine Development



PhRMA Research & Hope Award for Academic or Public Research in Vaccine Development

Douglas R. Lowy, MD
National Cancer Institute

John T. Schiller, PhD
National Cancer Institute

Drs. Lowy and Schiller are receiving the 2013 PhRMA Research & Hope Award for Academic or Public Research for the discovery of the human papilloma virus (HPV) vaccine for the prevention of cervical cancer. For more information on their pivotal work, see the video and bios.


PhRMA Research & Hope Award for Patient and Community Health Award for Patient and Community Health

  • Linda Yu-Sing Fu, M.D., M.Sc.
    Children’s National Medical Center (CNMC)

Dr. Fu, on behalf of her team at CNMC, is receiving the 2013 PhRMA Research & Hope Award for Patient and Community Health for their efforts to increase awareness of the importance of childhood immunization and raise the quality of immunization delivery to an at-risk population in the District of Columbia. For more information, see the video and bio.


Awards Program

The 2013 Research & Hope Awards dinner will feature welcoming remarks by PhRMA President and CEO John J. Castellani and PhRMA Chairman of the Board and Chairman/CEO of Celgene Corporation Robert J. Hugin, a keynote address by Tom Frieden, MD, MPH, Director of the Centers for Disease Control and Prevention (CDC), and the awards ceremony. The program will be emceed by WUSA*9 Anchor Anita Brikman.


2013 Partners

The following partners have been key to this year's Research and Hope Awards. Learn more about these organizations by clicking on their logo.

 ACS CAN, the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard.



ANA is the only full-service professional organization representing the interests of the nation's 3.1 million registered nurses through its constituent and state nurses associations and its organizational affiliates. ANA advances the nursing profession by fostering high standards of nursing practice, promoting the rights of nurses in the workplace, projecting a positive and realistic view of nursing, and by lobbying the Congress and regulatory agencies on health care issues affecting nurses and the public.



The American Osteopathic Association (AOA) proudly represents its professional family of more than 104,000 osteopathic physicians (DOs) and osteopathic medical students; promotes public health; encourages scientific research; serves as the primary certifying body for DOs; is the accrediting agency for osteopathic medical schools; and has federal authority to accredit hospitals and other health care facilities. 



Malaria No More logo


Malaria No More is determined to end malaria deaths. We’re helping the world get it done by engaging leaders, rallying the public, and delivering life-saving tools and education to families across Africa. Founded in 2006 by business leaders Ray Chambers and Peter Chernin, Malaria No More is working to create a world in which no one dies from a mosquito bite.



The National Association of School Nurses (NASN) is a non-profit specialty nursing organization, incorporated in 1979, which represents school nurses exclusively. NASN has 16,000 members and 49 affiliates, including the District of Columbia and overseas. NASN advances the specialty practice of school nursing to improve the health and academic success of all students.



2013 Media Partners

The following media outlets are key partners in the PhRMA Research and Hope Awards. Learn more about their organizations by clicking on the logo.

W*USA 9 is part of Gannett Co., Inc., a leading international news and information company that publishes 101 daily newspapers in the US, including USA TODAY, the nation’s largest selling daily newspaper. 



 BioCentury Publications, Inc. is recognized as the leading provider of value-added information, analysis and data essential to the development and sustainability of life science ventures.


PHARMACEUTICAL EXECUTIVE covers the intersection between strategy and policy globally. We provide pharma executives with information and new ideas on strategy, regulation, marketing, finance, IT and R&D. PHARMACEUTICAL EXECUTIVE audience is over 175,000 pharmaceutical executives worldwide.




pharmaphorum media provides digital content marketing and communications solutions for the pharmaceutical sector, supported by the industry leading channel, a digital podium for thought leadership and innovation within healthcare.




“The Pink Sheet” delivers expert, in-depth analysis of regulatory, legislative, legal and business developments - and their bottom-line impact on the industry. Its comprehensive coverage is vital for successful business development and commercialization strategies that drive profits.


SCRIP Intelligence is the leading source of vital news and strategic analysis for the global pharmaceutical industry. Our extensive network of analysts, journalists and key opinion leaders provide you with timely business-critical market and competitor intelligence.



Award Criteria

Recipients of the Biopharmaceutical Industry Research and Academic or Public Research Awards were selected by the Scientific Advisory Board of the PhRMA Foundation following an open nominations process. The recipient of the Patient and Community Health Award was chosen by an inter-departmental committee of representatives from PhRMA.



Click to Review the 2012 PhRMA Research & Hope Awards Program

PhRMA Research and Hope Awards logo


On September 12, 2012, PhRMA, along with distinguished members of the medical and patient community, held our national awards program in Washington DC to present awards honoring individuals and organizations who have contributed significantly to the advancement of hope and research in the fight against Alzheimer's disease.

Resources from the Awards Program

Researching Alzheimer's Medicines: Setbacks and Stepping Stones

Alzheimer’s disease is among the most devastating diseases anyone can face and it is among the most costly for the health care system. Innovative new medicines will be central to treating, slowing, preventing, and even curing Alzheimer’s but the path from basic research to new treatments is not a straight line. Rather, many setbacks occur along the way which guide and redirect research studies.

Since 1998, 101 drug development projects have become inactive, of which 86 have been definitively discontinued. In that time three new medicines have been approved to treat the symptoms of Alzheimer’s disease, so inactive projects outnumber approved medicines 34 to 1. In the face of these deeply disappointing setbacks, researchers take the findings from the unsuccessful projects and use that new information to step forward and continue searching. Read the Study

Medicines in Development for Alzheimer's Disease

There are more than five million Americans living with Alzheimer’s. Hope for the future lies in medical innovation. America’s biopharmaceutical research companies are investigating or developing 93 medicines for patients with Alzheimer’s and other dementias. This research will help to bring us closer to our goal of tackling and eventually conquering this debilitating disease. Learn about these developments and read the report here.

Awards Program

Awards were given in the following categories:

The Research & Hope Award for Academic Research in Alzheimer's: Presented to individuals or a team from the academic community for outstanding research in the search for a cure of Alzheimer's disease [Awardee bios] [video]

The Research & Hope Award for Biopharmaceutical Industry Research in Alzheimer's: Presented to individuals or team from a biopharmaceutical company for outstanding research in the search for a cure for Alzheimer's disease [Awardee bios]

The Research & Hope Award for Patient Advocacy: This award is presented to an individual or organization that has had significant impact supporting and advocating for legislative or regulatory health policy issues.  Their work has increased awareness, funding for research or access to care.  The award recognizes the involvement, commitment and achievement to the fight against Alzheimer's. [Awardee bio] [video]

The Research & Hope Award:  Volunteer Champion: This award is presented to an individual who has significantly affected the lives of patients and/or home caregivers in a charitable or humanitarian way.  The Volunteer Champion recognizes individuals and caregivers who give selflessly to help other in need. [Awardee bio] [video]

The event was held at the Newseum in Washington DC.

For more information about the PhRMA Research & Hope Awards, including questions about the 2013 nominations process, contact 202-835-3460 or email us.

2012 Co-Hosts

The following organizations are Co-Hosts and key partners in the PhRMA Research and Hope Awards. You are encouraged to learn more about their organizations and the role they play in advancing the fight against Alzheimer's disease. [view the sponsor video]

AFA Logo                                        

Alzheimer's Foundation of America



NAC Logo


National Alliance for Caregiving



National Association for Home Care & Hospice logo


National Association for Home Care & Hospice



Learn about previous Discoverers Awards winners. 2011  2010

2012 Media Partners

The following media outlets are key partners in the PhRMA Research and Hope Awards. Learn more about their organizations by clicking on the logo.

Pharmaceutical Technology logo





Scrip Intelligence logo





The Pink Sheet logo`




More On PhRMA — powered by PhRMApedia


Cost in Context